Fatty Liver Foundation to Amplify the Voices of People with NAFLD/NASH and Highlight New NAFLD/NASH Screening Initiatives While Attending The Liver Meeting® 2021

FOR IMMEDIATE RELEASE

Thursday, November 11, 2021, Boise, IDAHO The Fatty Liver Foundation (FLF) today announced its activities while attending the 72nd American Association for the Study of Liver Diseases (AASLD) Annual Meeting, taking place from November 12 to 15, 2021. 

In this virtual environment of The Liver Meeting Digital Experience™ (TLMdX), FLF aims to highlight progress toward innovations in NAFLD/NASH screening and treatment, including a public-private partnership financing initiative led by FLF to promote and invest in early detection of NAFLD/NASH, and to amplify the voices of NAFLD/NASH communities whose health experiences are most often silenced. 

Together with our partners, FLF is contributing while attending The Liver Meeting® 2021 in the following ways: 

Friday, November 12 to Monday, November 15

  • Exhibits

Visit FLF’s virtual exhibit booth to learn more about FLF’s impact initiatives and programs and the opportunity to schedule a meeting with our leadership team members.  

 

Saturday, November 13 | 09:00 AM – 10:00 AM EST

  • Patient Forum | Patient Keynote

How Physician-Patient Relationships Can Improve Liver Disease Care and Research

Wayne Eskridge, President and Co-Founder, FLF 

 

Saturday, November 13 | 11:00 AM – 11:30 AM EST

  • Patient Forum | Abstract Tour

NAFLD: Presenting four abstracts of interest to the patient community in the area of NAFLD. 

Wayne Eskridge, President and Co-Founder, FLF

 

“FLF is proud to be participating while attending The Liver Meeting® 2021 hosted by AASLD. We join in supporting and enhancing the resilience of communities, researchers, clinicians, patient advocates, and all who are committed to preventing and curing liver disease,” said Wayne Eskridge, CEO and Co-Founder of FLF. “This year, we’re excited to be present as an exhibitor to share and showcase FLF’s impact initiatives and programs, including the NAFLD Screening Fund, Screening for NAFLD/NASH (SUNN) Studies, The Wellness League, and patient education activities.” 

 

About the Fatty Liver Foundation

The Fatty Liver Foundation is a non-profit patient organization dedicated to improving the identification, diagnosis, treatment and support of people living with fatty liver, NAFLD or NASH through awareness, screening, education, and patient outreach. FLF’s goal is to improve the lives of both asymptomatic and diagnosed patients by raising awareness, advancing wellness screening, educating patients, and championing the development of responsive support systems for individuals of the growing epidemic of fatty liver disease. Connect with us on www.fattyliverfoundation.org, Facebook (Fatty Liver Foundation JUST LIVER NEWS), Twitter (@LiverSaver), and YouTube (Fatty Liver Foundation).  

 

About the NAFLD Screening Fund

With recent advancements in the diagnostics and potential treatments for NAFLD, screening and testing are now the critical nexus between identification of disease and effective intervention. To meet this need, the NAFLD Screening Fund’s primary objective is to scale-up evidence-based screening and testing for NAFLD. Funded activities will boost the screening practices needed to identify asymptomatic disease and staging of NAFLD/NASH patients.

The expansion of screening and staging of fatty liver disease is a model of community outreach that has been proven by FLF in medical and community-based settings. The Fund’s impact will be expanded education and awareness of NAFLD, achieved through screening, which has been shown to empower individuals’ ownership and participation in their health and healthcare. Through multiple site collaborations, new screening technologies, improved data management systems, and more trained personnel, the Fund will be leveraged to rapidly scale up community screening efforts. The NAFLD Screening Fund will be the catalyst for greater patient engagement in research and development, including treatment preparedness as new therapies become available. It is a mechanism through which many streams of financial support, both public and private, can be coordinated and focused on this rapidly growing health threat.

Learn how you can help support the NAFLD Screening Fund and address this significant unmet need by contacting the Fund’s Secretariat at [email protected]

 

Media Contact

Fatty Liver Foundation

Henry E. Chang | Mobile +1 917 400 8900 | [email protected]




#  #  #


Click for our online community

connect